Published in the prestigious International Journal of Molecular Sciences. A new article on the DOS (Dual Ovarian Stem Cell Therapy) method, featuring an overview of the most advanced treatment technologies

Published in the Journal of Perinatal Medicine. A few months ago, Professor Ljubić’s team published an article in the prestigious European journal, the Journal of Perinatal Medicine, exploring the specificities

Published in the journal Investigations in Gynecology Research & Women’s Health. Professor Ljubić’s team recently published an original method for ovarian rejuvenation — DOS – Dual Ovarian Stem cell Therapy)

Published in International Journal of Endocrinology Abstract There is a rising incidence of infertility worldwide, and many couples experience difficulties conceiving nowadays. Thyroid autoimmunity (TAI) is recognized as one of

Published in International Journal of Fertility and Sterility Abstract Background: Premature ovarian failure (POF) can be found in 1% of women at the age of 35-40, mostly due to unknown

Published in Research Square Abstract OBJECTIVES Stem cell-based therapies are emerging enormously as a ray of hope and therapeutic alternative for ovarian rejuvenation, regeneration and follicular development in women with

Published in Frontiers In Endocrinology Abstract Premature ovarian insufficiency is a common disorder affecting young women and represents the worst-case ovarian scenario due to the substantial impact on the reproductive

Published in Frontiers In Endocrinology Abstract Usually poor ovarian response (POR) to gonadotropins reflects a diminished ovarian reserve (DOR) that gives place to few recruitable follicles despite aggressive stimulation. The

Published in International Journal of Reproduction, Contraception, Obstetrics and Gynecology Abstract Background: Stem cells are undifferentiated cells with a potential for self- renewal and differentiation into multiple mature cell types.

Published in Clinical and Experimental Reproductive Medicine Abstract Objective As clinicians and patients await consensus on intraovarian platelet-rich plasma (PRP) treatment, this project evaluated contemporary research trends in the literature.